Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1/2, First-in-human, Multicenter Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
A Study of Emi-Le in Participants with Solid Tumors
Triple Negative Breast CancerBreast CancerEndometrial Cancer+4 more
Estimated
~$10 – $8,750
Day One Biopharmaceuticals, Inc.NCT05377996
Phase 2
A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
This is a phase 2 study to test the effectiveness (anti-tumor activity) of the combination of the study drugs, Senaparib and Temozolomide, in patients with cle…
Ovary CancerFallopian Tube CancerPrimary Peritoneal Cavity Cancer
Estimated
~$10 – $6,250
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06617923